These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 3116919
1. Biological activity of BO-1236, a new antipseudomonal cephalosporin. Nakagawa S, Sanada M, Matsuda K, Hazumi N, Tanaka N. Antimicrob Agents Chemother; 1987 Jul; 31(7):1100-5. PubMed ID: 3116919 [Abstract] [Full Text] [Related]
2. In vitro and in vivo antibacterial activities of BO-1341, a new antipseudomonal cephalosporin. Nakagawa S, Sanada M, Matsuda K, Hashizume T, Asahi Y, Ushijima R, Ohtake N, Tanaka N. Antimicrob Agents Chemother; 1989 Sep; 33(9):1423-7. PubMed ID: 2510590 [Abstract] [Full Text] [Related]
3. Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels. Fung-Tomc J, Dougherty TJ, DeOrio FJ, Simich-Jacobson V, Kessler RE. Antimicrob Agents Chemother; 1989 Apr; 33(4):498-502. PubMed ID: 2499250 [Abstract] [Full Text] [Related]
4. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests. Jones RN, Barry AL, Thornsberry C, Gerlach EH, Fuchs PC, Gavan TL, Sommers HM. J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985 [Abstract] [Full Text] [Related]
5. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa. van Klingeren B. J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171 [Abstract] [Full Text] [Related]
6. In vitro activity of a new cephalosporin ME-1206 compared with other agents. Chin NX, Zhang YX, Neu HC. Diagn Microbiol Infect Dis; 1991 Sep; 14(5):417-24. PubMed ID: 1797456 [Abstract] [Full Text] [Related]
9. In vitro activity of BMY-28142, a new cephalosporin. Norden CW, Neiderriter K. Chemotherapy; 1987 Sep; 33(1):15-7. PubMed ID: 3103990 [Abstract] [Full Text] [Related]
13. The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin. Acred P, Ryan DM, Sowa MA, Watts CM. J Antimicrob Chemother; 1981 Sep; 8 Suppl B():247-55. PubMed ID: 19802994 [Abstract] [Full Text] [Related]
14. In-vitro and in-vivo antibacterial activities of E1040, a new cephalosporin with potent antipseudomonal activity. Hiruma R, Otsuki M, Tashima M, Obana Y, Nishino T. J Antimicrob Chemother; 1990 Dec; 26(6):769-81. PubMed ID: 2127928 [Abstract] [Full Text] [Related]
15. In-vitro activity of ceftazidime against Pseudomonas aeruginosa: and its stability to pseudomonal beta-lactamases. Livermore DM, Williams RJ, Williams JD. J Antimicrob Chemother; 1981 Sep; 8 Suppl B():163-7. PubMed ID: 19802980 [Abstract] [Full Text] [Related]
17. Antibacterial activity of BMY-28142, a novel broad-spectrum cephalosporin. Tomatsu K, Ando S, Masuyoshi S, Hirano M, Miyaki T, Kawaguchi H. J Antibiot (Tokyo); 1986 Nov; 39(11):1584-91. PubMed ID: 3539901 [Abstract] [Full Text] [Related]
18. Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics. Kessler RE, Bies M, Buck RE, Chisholm DR, Pursiano TA, Tsai YH, Misiek M, Price KE, Leitner F. Antimicrob Agents Chemother; 1985 Feb; 27(2):207-16. PubMed ID: 3885849 [Abstract] [Full Text] [Related]